Research Platforms

The team is involved in research related to neurocognitive impairments and dementia, focusing on disease biomarkers.

Research Studies:

• Longitudinal Observational Studies
• Clinical Trials
  

Research Platforms:

• Neuropsychological Assessments
• Assess global cognition and five other domains including episodic memory, executive function, visuospatial abilities, attention and language
• Fluid Biomarkers
• Blood and Cerebrospinal Fluid: Amyloid, Tau, Genetics, Neuroinflammation, Neurodegeneration Markers
• Neuroimaging
• Computerised Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET)